NGT BioPharma Consultants Welcomes Michelle McGuinness, VP Regulatory Strategy & Submissions
NGT BioPharma Consultants Welcomes Michelle McGuinness, VP Regulatory Strategy & Submissions
As we continue to face business impacts of COVID, a new normal may be emerging in regulated industries, such as pharma and medical devices, when it comes to site visits and audits. As agencies like the FDA continue to rely on the virtual inspection, we need to take a look at the process, including review of documents and processes. How can these inspections be more hands-on and eyes-on, allowing for efficient and accurate outcomes? In this episode we bring a panel disucssion to help us better understand the intricacies of remote inspection featuring Dr. Ajaz Hussain, Dr. Alton Johnson, and Steve Thompson.
Our people are at the core of our business. We are featuring the amazing individuals who make NGT BioPharma Consultants a proficient and principled team to work with. Today we highlight Dr. Robert Dennehy, NGT’s Crystallization and Solid State Expert.
NGT BioPharma’s Dr. Robert Dennehy is appointed to Strategic Advisory Board at CatSci.
Our people are at the core of our business. We are featuring the amazing individuals who make NGT BioPharma Consultants a proficient and principled team to work with. Today we highlight Dr. Robert Dennehy, NGT’s Crystallization and Solid State Expert.
